- RxSight, Inc. to Present at the Bank of America Healthcare Conference
- RxSight, Inc. to Report First Quarter Financial Results on May 6, 2024
- RxSight Announces Commercial Launch of its Newest Light Adjustable Lens™, the LAL+™, and Features Multiple Doctor Presentations at the Upcoming ASCRS Annual Meeting
- RxSight, Inc. to Participate in the 23rd Annual Needham Virtual Healthcare Conference
- RxSight, Inc. to Participate in the 34th Annual Oppenheimer Healthcare Conference
- RxSight, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results
- RxSight, Inc. to Report Fourth Quarter and Full Year 2023 Financial Results on February 28, 2024
- RxSight, Inc. Announces Preliminary Unaudited Fourth Quarter and Full-Year 2023 Financial and Operational Results and 2024 Guidance
- RxSight, Inc. to Present at the J.P. Morgan Healthcare Conference
- RxSight, Inc. Reports Third Quarter 2023 Financial Results
More ▼
Key statistics
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 60.00 |
---|---|
High | 61.13 |
Low | 59.59 |
Bid | 60.00 |
Offer | 60.23 |
Previous close | 59.63 |
Average volume | 399.54k |
---|---|
Shares outstanding | 37.17m |
Free float | 30.36m |
P/E (TTM) | -- |
Market cap | 2.22bn USD |
EPS (TTM) | -1.42 USD |
Data delayed at least 15 minutes, as of May 03 2024 18:58 BST.
More ▼